| http://www.w3.org/ns/prov#value | - ith up to 12 presenting companies and 40 potential investors, including Abbott Labs, DSM, Cargill, Herbalife, Nestle Health Sciences, Kerry Group, Unilever, Novus, Seventure and Tate & Lyle Ventures.Broad range of opportunitiesOf particular interest to investors is technology and innovation targeting health conditions in brain function and memory; diabetes and weight loss; energy; digestive distre
|
